1. Home
  2. DNTH vs NG Comparison

DNTH vs NG Comparison

Compare DNTH & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • NG
  • Stock Information
  • Founded
  • DNTH 2015
  • NG 1984
  • Country
  • DNTH United States
  • NG Canada
  • Employees
  • DNTH N/A
  • NG N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • NG Precious Metals
  • Sector
  • DNTH Health Care
  • NG Basic Materials
  • Exchange
  • DNTH Nasdaq
  • NG Nasdaq
  • Market Cap
  • DNTH 1.4B
  • NG 1.5B
  • IPO Year
  • DNTH N/A
  • NG N/A
  • Fundamental
  • Price
  • DNTH $33.73
  • NG $7.88
  • Analyst Decision
  • DNTH Strong Buy
  • NG Strong Buy
  • Analyst Count
  • DNTH 11
  • NG 3
  • Target Price
  • DNTH $65.22
  • NG $10.17
  • AVG Volume (30 Days)
  • DNTH 503.3K
  • NG 3.7M
  • Earning Date
  • DNTH 11-05-2025
  • NG 10-01-2025
  • Dividend Yield
  • DNTH N/A
  • NG N/A
  • EPS Growth
  • DNTH N/A
  • NG N/A
  • EPS
  • DNTH N/A
  • NG N/A
  • Revenue
  • DNTH $4,854,000.00
  • NG N/A
  • Revenue This Year
  • DNTH N/A
  • NG N/A
  • Revenue Next Year
  • DNTH N/A
  • NG N/A
  • P/E Ratio
  • DNTH N/A
  • NG N/A
  • Revenue Growth
  • DNTH 17.87
  • NG N/A
  • 52 Week Low
  • DNTH $13.37
  • NG $2.26
  • 52 Week High
  • DNTH $40.16
  • NG $10.90
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 47.36
  • NG 42.82
  • Support Level
  • DNTH $32.28
  • NG $7.68
  • Resistance Level
  • DNTH $35.40
  • NG $8.37
  • Average True Range (ATR)
  • DNTH 1.62
  • NG 0.47
  • MACD
  • DNTH -0.20
  • NG -0.22
  • Stochastic Oscillator
  • DNTH 27.78
  • NG 8.14

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About NG Novagold Resources Inc.

Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.

Share on Social Networks: